Chloroquine/Primaquine

DRUG2 trials

Sponsors

University of Oxford

Conditions

Vivax Malaria

Phase 3

Study on the Treatment of Vivax Malaria

CompletedNCT01074905

University of OxfordVivax Malaria

Start: 2010-05-31End: 2012-10-31Updated: 2013-08-28

Phase 4

Estimating the Risk of Plasmodium Vivax Relapses in Afghanistan

CompletedNCT01178021

University of OxfordVivax Malaria

Start: 2009-08-31End: 2014-02-28Updated: 2019-01-15

Related Papers

Population heterogeneity in Plasmodium vivax relapse risk

PLoS neglected tropical diseases2022-12-1916 citations

Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria

Clinical Infectious Diseases2018-05-1677 citations

Closing the translation gap for justice requirements in international research.

2012-03-1617 citations